Insider ownership feed
Showing Forms 3/4/5 accepted since 31 May 2026. Each row keeps issuer, reporting owner, reported value, role, and SEC evidence together.
Recent insider signals
Use the card actions for issuer context, owner profile, and SEC evidence.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Form 4 insider conviction
Role, issuer, transaction value, repeat activity, and SEC evidence.
Fresh reports
19,580
Forms 3, 4, and 5 filed in the current review window.
Visible buy/sell mix
0/3
Positive/negative net value among the preview cards.
Visible net value
-$3,904,991
Directional preview only; verify transaction rows and footnotes.
Newest evidence
04 Jun 2026
Use recency to separate fresh activity from stale insider stories.
Signal checks
positive net value and transaction code
multiple insiders or repeated filings
director, officer, or 10% owner context
issuer facts, 13D/G stakes, and 13F holders
SEC-verifiable Form 4 path
Open the filing, then follow the insider, issuer, or related ownership context.
Faisal Mehmud filed Form 4 for Medicus Pharma Ltd. (MDCX). Role/context: Chief Medical Officer. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Ben Haim Shlomi filed Form 4 for JFrog Ltd (FROG). Role/context: CHIEF EXECUTIVE OFFICER, Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Steven R. Shane filed Form 4 for Science Applications International Corp (SAIC). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Sanchez Oscar Iglesias filed Form 4 for Codere Online Luxembourg, S.A. (CDRO). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Christopher D. Brown filed Form 4 for 908 Devices Inc. (MASS). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
John W. Gibson filed Form 4 for ONE Gas, Inc. (OGS). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
| Security | Issuer | Reporting owner / CIK | Reported value | Report date | Actions |
|---|---|---|---|---|---|
| MDCX | Medicus Pharma Ltd. | Faisal Mehmud CIK 0002047946 | $0 | 03 Jun 2026 | |
| FROG | JFrog Ltd | Ben Haim Shlomi CIK 0001823009 | -$3,726,066 | 02 Jun 2026 | |
| SAIC | Science Applications International Corp | Steven R. Shane CIK 0001585983 | $0 | 03 Jun 2026 | |
| CDRO | Codere Online Luxembourg, S.A. | Sanchez Oscar Iglesias CIK 0002124727 | -$4,325 | 02 Jun 2026 | |
| MASS | 908 Devices Inc. | Christopher D. Brown CIK 0001836988 | -$174,600 | 03 Jun 2026 | |
| OGS | ONE Gas, Inc. | John W. Gibson CIK 0001239209 | $0 | 03 Jun 2026 | |
| CSX | CSX CORP | John J. Zillmer CIK 0001188262 | -$464,500 | 03 Jun 2026 | |
| OGS | ONE Gas, Inc. | Pattye L. Moore CIK 0001185026 | $0 | 03 Jun 2026 | |
| KEYS | Keysight Technologies, Inc. | James Cullen CIK 0001142630 | -$1,039,741 | 02 Jun 2026 | |
| CMRC | Commerce.com, Inc. | Charles D. Cassidy CIK 0001979522 | $0 | 02 Jun 2026 | |
| CCCC | C4 Therapeutics, Inc. | Kenneth Carl Anderson CIK 0001824862 | $0 | 01 Jun 2026 | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Judith L. Swain CIK 0001413573 | $0 | 03 Jun 2026 | |
| ULCC | Frontier Group Holdings, Inc. | Alexandre Clerc CIK 0002007448 | -$30,006 | 02 Jun 2026 | |
| SAIC | Science Applications International Corp | Michael Scott Rogers CIK 0002130173 | $0 | 03 Jun 2026 | |
| DRS | Leonardo DRS, Inc. | Jason Rinsky CIK 0002107246 | -$181,153 | 03 Jun 2026 | |
| CIK 0001567892 | Keenova Therapeutics plc | Sophia J. Langlois CIK 0001903130 | $0 | 02 Jun 2026 | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Diane E. Sullivan CIK 0001968736 | $0 | 03 Jun 2026 | |
| STWD | STARWOOD PROPERTY TRUST, INC. | Barry S. Sternlicht CIK 0001034657 | $0 | 02 Jun 2026 | |
| MDCX | Medicus Pharma Ltd. | Sara R. May CIK 0002048946 | $0 | 03 Jun 2026 | |
| CIK 0001567892 | Keenova Therapeutics plc | Scott Hirsch CIK 0002024619 | $0 | 02 Jun 2026 | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Christopher J. Sobecki CIK 0001053892 | $0 | 03 Jun 2026 | |
| SAIC | Science Applications International Corp | Donna S. Morea CIK 0001212424 | $0 | 03 Jun 2026 | |
| SCOR | COMSCORE, INC. | Stuart Brian Frankel CIK 0002138705 | $0 | 28 May 2026 | |
| CIK 0001567892 | Keenova Therapeutics plc | Paul Efron CIK 0002024711 | $0 | 02 Jun 2026 | |
| DELL | Dell Technologies Inc. | Richard J. Rothberg CIK 0001680902 | $0 | 03 Jun 2026 | |
| MDCX | Medicus Pharma Ltd. | Patrick J. Mahaffy CIK 0001266569 | $0 | 03 Jun 2026 | |
| CIK 0001567892 | Keenova Therapeutics plc | Katina Dorton CIK 0001617541 | $0 | 02 Jun 2026 | |
| AAOI | APPLIED OPTOELECTRONICS, INC. | Min-Chu (mike) Chen CIK 0001587425 | -$1,657,647 | 02 Jun 2026 | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Ivan H. Cheung CIK 0002042690 | $0 | 03 Jun 2026 | |
| CBUS | Cibus, Inc. | Kimberly A. Box CIK 0001555054 | $0 | 02 Jun 2026 | |
| SAIC | Science Applications International Corp | Milford W. McGuirt CIK 0001816394 | $0 | 03 Jun 2026 | |
| OPAL | OPAL Fuels Inc. | Nadeem Nisar CIK 0001827382 | +$34,450 | 02 Jun 2026 | |
| EXE | EXPAND ENERGY Corp | Marcel Teunissen CIK 0001730935 | +$185,760 | 04 Jun 2026 | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Sam L. Barker CIK 0001226877 | $0 | 03 Jun 2026 | |
| THG | HANOVER INSURANCE GROUP, INC. | Bryan J. Salvatore CIK 0001709075 | -$3,045,349 | 03 Jun 2026 | |
| CIK 0001567892 | Keenova Therapeutics plc | Leslie E. Donato CIK 0001784795 | $0 | 02 Jun 2026 | |
| SAIC | Science Applications International Corp | Katharina G. Mcfarland CIK 0001711062 | $0 | 03 Jun 2026 | |
| ILMN | ILLUMINA, INC. | Patricia Leckman CIK 0002015062 | -$127,068 | 02 Jun 2026 | |
| MDCX | Medicus Pharma Ltd. | Larry Kaiser CIK 0002048184 | $0 | 03 Jun 2026 | |
| SPE | SPECIAL OPPORTUNITIES FUND, INC. | Andrew Dakos CIK 0001341021 | -$95,117 | 02 Jun 2026 | |
| CIK 0001567892 | Keenova Therapeutics plc | Paul Bisaro CIK 0001237253 | $0 | 02 Jun 2026 | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Philippe Amouyal CIK 0001376854 | $0 | 03 Jun 2026 | |
| SAIC | Science Applications International Corp | Carolyn B. Handlon CIK 0001705809 | $0 | 03 Jun 2026 | |
| CIK 0001567892 | Keenova Therapeutics plc | Jon Zinman CIK 0002001886 | $0 | 02 Jun 2026 | |
| AVTX | Avalo Therapeutics, Inc. | Kevin Robert Lind CIK 0001677036 | $0 | 02 Jun 2026 | |
| AVTX | Avalo Therapeutics, Inc. | Samantha Truex CIK 0002017156 | $0 | 02 Jun 2026 | |
| AVTX | Avalo Therapeutics, Inc. | Gilla Kaplan CIK 0001247024 | $0 | 02 Jun 2026 | |
| AVTX | Avalo Therapeutics, Inc. | Aaron Kantoff CIK 0001862734 | $0 | 02 Jun 2026 | |
| AVTX | Avalo Therapeutics, Inc. | Michael Thomas Heffernan CIK 0001448914 | $0 | 02 Jun 2026 | |
| CIK 0001567892 | Keenova Therapeutics plc | Marc J. Yoskowitz CIK 0001617306 | $0 | 02 Jun 2026 |